Navigation Links
AMD LASERS Announces Partnerships With Three Industry-Leading Companies
Date:10/26/2009

INDIANAPOLIS, Oct. 26 /PRNewswire/ -- AMD LASERS, the world leader in comprehensive and affordable laser technology, today announced a strategic partnership aimed at providing even more value for dental professionals that purchase the Picasso diode dental laser. Partners include industry leaders 1-800-DENTIST®, Fortune Management, and Cetylite Industries. While supplies last, AMD customers who purchase a Picasso laser package will receive a voucher for Everything is Marketing: The Ultimate Strategy for Dental Practice Growth (list price $24.95), a Gift Certificate for a FREE Practice Analysis (valued at $1,500), and a complimentary Cetacaine® Topical Anesthetic LIQUID Kit (value of $63).

"We are delighted to have the opportunity to partner with these industry leading companies," said Alan Miller, President and CEO of AMD LASERS. "Our customers are our greatest asset and creating such a high quality, value-added promotion will make their Picasso purchase experience even more pleasant and relevant to their business. At a value of almost $1,600, coupled with the world's most affordable laser, we are confident this promotion will help with our goal of having a laser in every operatory."

AMD LASERS, founded in 2006, is the global leader at providing comprehensive and affordable diode laser technology for dental professionals preparing to take their practice to the next level. The integration of Picasso, our high quality laser technology, enables thousands of dental practices to provide advanced patient care with ease. AMD LASERS customers also receive full-service customer care support from our knowledgeable and friendly staff. For more information about AMD LASERS, please call 866-999-2635, 317-202-9530, or visit us online at www.AMDLASERS.com.

SOURCE AMD LASERS


'/>"/>
SOURCE AMD LASERS
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ReportsnReports.com adds "Pulmonary Arterial ... report that provides an overview of the PAH ... stages, therapeutics assessment by drug target, mechanism of ... type, along with latest updates, and featured news ... involved in the therapeutic development for Pulmonary Arterial ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... ... enterprise focused entirely on patients with cancer, today announced that Lynne Malestic, RN, ... the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... ... April 29, 2016 , ... Coalition ... muscular dystrophy, and funding for Duchenne research, participated in the April 25 U.S. ... Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott Conference Center in ...
(Date:4/29/2016)... ... 29, 2016 , ... The Society for Assisted Reproductive Technology ... required to report in vitro fertilization (IVF) delivery rates to both ... of assisted reproductive technologies in the United States. , This year, SART’s ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... The ... the workforce is aging – meaning that there is an urgent need for highly ... and interactive training solution, delivering a multi-pronged approach to train and retain care managers, ...
Breaking Medicine News(10 mins):